| Literature DB >> 32821284 |
Nayara Fraccari Pires1, Helio José Coelho-Júnior2,3, Bruno Bavaresco Gambassi2,4, Ana Paula Cabral de Faria1, Alessandra Mileni Versuti Ritter1, Catarina de Andrade Barboza1,2, Silvia Elaine Ferreira-Melo1, Bruno Rodrigues1,2, Heitor Moreno Júnior1.
Abstract
AIM: The present study compared the acute effects of aerobic (AER), resistance (RES), and combined (COM) exercises on blood pressure (BP) levels in people with resistant hypertension (RH) and nonresistant hypertension (NON-RH).Entities:
Mesh:
Substances:
Year: 2020 PMID: 32821284 PMCID: PMC7416229 DOI: 10.1155/2020/8157858
Source DB: PubMed Journal: Cardiovasc Ther ISSN: 1755-5914 Impact factor: 3.023
General characteristics of resistant hypertensive (RH) subjects and non-resistant hypertensive (NON-RH) subjects according to clinical and biochemical data and antihypertensive (anti-HT) drugs used by the subgroups.
| RH | NON-RH |
| |
|---|---|---|---|
| ( | ( | ||
| Clinical data | |||
| Age (years) | 60 ± 9 | 54 ± 13 | 0.66 |
| Female gender, | 6 (60) | 5 (50) | 1 |
| Diabetes mellitus, | 10 (100) | 5 (50) | 0.09 |
| BMI (kg/m2) | 31 ± 5 | 32 ± 7 | 0.18 |
| Fat-free mass (kg) | 54 (43-71) | 61 (47-82) | 0.40 |
| Fat mass (kg) | 25 ± 10 | 26 ± 14 | 0.32 |
| Total body water (L) | 75 ± 2 | 75 ± 3 | 0.17 |
| Basal metabolic rate (cal/day) | 1765 ± 482 | 1996 ± 540 | 0.39 |
| Biomarkers | |||
| HbA1C (%) | 7 ± 2 | 6 ± 0.7 | 0.13 |
| Glucose (mg/mL) | 97 (89-139) | 98 (94-134)∗ | 0.07 |
| Creatinine (mg/mL) | 0.8 (0.1-1.1) | 0.8 (0.7-0.9) | 0.81 |
| Aldosterone (pg/mL) | 100 ± 141 | 132 ± 95 | 0.64 |
| Creat clear (mL/min/1.73m2) | 83 ± 66 | 89 ± 65 | 0.86 |
| Cholesterol (mg/mL) | 188 ± 48 | 175 ± 40 | 0.55 |
| HDL-c (mg/mL) | 44 ± 9 | 38 ± 7∗ | 0.07 |
| LDL-c (mg/mL) | 109 ± 35 | 106 ± 46 | 0.88 |
| Triglycerides (mg/mL) | 135 (90-214) | 143 (105-205) | 0.97 |
| Anti-HT drugs | |||
| Number of classes | 4 ± 1 | 2 ± 1 | 0.13 |
| Diuretics, | 10 (100) | 5 (50)∗ | 0.03 |
| Spironolactone, | 2 (20) | 2 (20) | 1 |
| Beta-blockers, | 8 (80) | 6 (60) | 0.63 |
| ACEIs and ARBs, | 5 (50) | 7 (70) | 0.65 |
| CCBs, | 8 (80) | 3 (30) | 0.07 |
| Others, | 0 | 0 | 1 |
Values are expressed as mean ± standard deviation or median (1st, 3rd quartiles), according to data distribution. RH: resistant hypertensive; NON-RH: non-resistant hypertensive; BMI: body mass index; HbA1C: glycated hemoglobin; Creat clear: creatinine clearance; LDL and HDL: low- and high-density lipoproteins, respectively; anti-HT: antihypertensive drugs; ACEIs: angiotensin-converting enzyme inhibitors; ARBs: angiotensin receptor blockers; CCBs: calcium channel blockers.
Figure 1Ambulatory systolic blood pressure (a) and diastolic blood pressure (b) levels after aerobic, resistance, and combined exercises in RH. aP < 0.05 aerobic in comparison to baseline values; bP < 0.05 resistance in comparison to baseline values; cP < 0.05 combined in comparison to baseline values.
Figure 2Ambulatory systolic blood pressure (a) and diastolic blood pressure (b) levels after aerobic, resistance, and combined exercises in NON-RH. aP < 0.05 aerobic in comparison to baseline values; bP < 0.05 resistance in comparison to baseline values; cP < 0.05 combined in comparison to baseline values.
Area under the curve of the experimental sessions.
| RES | AER | COM | ||||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| Resistant hypertension | ||||||
| 24 h | ||||||
| SBP | 2618 | 18.2 | 2610 | 15.2 | 2535ab | 15.2 |
| DBP | 1049 | 11.5 | 1070a | 11.7 | 1052b | 9.8 |
| Awake-time | ||||||
| SBP | 1871 | 18.5 | 1798 | 19.4 | 1778ab | 16.3 |
| DBP | 787 | 12.0 | 771a | 13.0 | 752ab | 16.1 |
| Night-time | ||||||
| SBP | 1356 | 17.2 | 1361a | 18.2 | 1320ab | 19.8 |
| DBP | 469 | 12.9 | 468 | 13.2 | 468 | 17.7 |
| Nonresistant hypertension | ||||||
| 24 h | ||||||
| SBP | 1796 | 16.1 | 1767a | 14.1 | 1823ab | 16.5 |
| DBP | 1019 | 12.0 | 1004 | 13.3 | 1081ab | 16.3 |
| Awake-time | ||||||
| SBP | 1781 | 12.0 | 1741a | 12.0 | 1816ab | 15.6 |
| DBP | 1045 | 10.9 | 1005a | 12.1 | 1090ab | 17.1 |
| Night-time | ||||||
| SBP | 954 | 17.3 | 947 | 15.6 | 976ab | 19.8 |
| DBP | 365 | 11.4 | 373 | 12.8 | 397ab | 17.7 |
SBP = systolic blood pressure; DBP = diastolic blood pressure; SD = standard deviation; aP < 0.05 vs. strength; bP < 0.05 vs. aerobic.